Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: Outcome of a prospective study in postmenopausal Caucasian women

Diabetologia

Volumn 43, Issue 2, 2000, Pages 194-202

  Larsson, H ^a   Ahren B ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Glucagon secretion; Impaired glucose tolerance; Insulin sensitivity insulin secretion; Normal glucose tolerance; Type II diabetes

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

EID: 0033995503     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050029     Document Type: Article

References (36)

1. 1. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68: 1456-1467
2. 2. Kahn SE, Prigeon RL, McCulloch DK et al. (1993) Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663-1672
3. 3. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G (1997) Insulin resistance and hypersecretion in obesity. J Clin Invest 100: 1166-1173
4. 4. Clausen JO, Borch-Jensen K, Ibsen H et al. (1996) Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young, healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 98: 1195-1209
5. 5. Keen H, Jarrett RJ, McCartney P (1982) The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia 22: 73-78
6. 6. King H, Zimmet P, Raper LR, Balkau B (1984) The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow-up study. Diabetologia 26: 39-43
7. 7. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH (1988) The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319: 1500-1506
8. 8. Larsson H, Ahrén B (1996) Islet dysfunction in obese women with impaired glucose tolerance. Metabolism 45: 502-509
9. 9. Larsson H, Ahrén B (1996) Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39: 1099-1107
10. 10. Ahrén B, Pacini G (1997) Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance. Am J Physiol 273: E701-E707
11. 11. Lillioja S, Mott DM, Spraul M et al. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329: 1988-1992
12. 12. Haffner SM, Miettinen H, Gaskill SP, Stern MP (1995) Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 44: 1386-1391
13. 13. Haffner SM, Miettinen H, Gaskill SP, Stern MP (1996) Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 39: 1201-1207
14. 14. Larsson H, Ahrén B, Lindgärde F, Berglund G (1995) Fasting blood glucose in determining the prevalence of diabetes in a large, homogeneous population of Caucasian middle-aged women. J Intern Med 237: 537-541
15. 15. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223
16. 16. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr (1984) Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74: 1318-1328
17. 17. Larsson H, Ahrén B (1998) Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia 41: 772-777
18. 18. Dimitriadis GD, Pehling GD, Gerich JE (1985) Abnormal glucose modulation of islet A-and B-cell responses to arginine in non-insulin-dependent diabetes mellitus. Diabetes 34: 541-547
19. 19. Baron AD, Schaeffer L, Shragg P, Kolterman OG (1987) Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes 36: 274-283
20. 20. Assan R, Efendic S, Luft R, Cerasi E (1981) Dose-kinetics of pancreatic glucagon responses to arginine and glucose in subjects with normal and impaired pancreatic B cell function. Diabetologia 21: 452-459
21. 21. Hamaguchi T, Fukushima H, Uehara M et al. (1991) Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells. Diabetologia 34: 801-806
22. 22. World Health Organization Study Group on Diabetes mellitus (1985) Technical Report Series No 727, WHO
23. 23. Cerasi E (1975) Potentiation of insulin release by glucose in man. Acta Endocrinol 79: 511-534
24. 24. Grill V (1981) Time and dose dependencies for priming effect of glucose on insulin secretion. Am J Physiol 240: E24-E31
25. 25. Halter JB, Graf RJ, Porte D Jr (1979) Potentiation of insulin secretory responses by plasma glucose levels in man: Evidence that hyperglycemia in diabetes compensates for impaired glucose potentiation. J Clin Endocrinol Metab 48: 946-954
26. 26. Porte D Jr (1991) Banting lecture 1990. β-cells in type II diabetes mellitus. Diabetes 40: 166-180
27. 27. Taylor SI, Accili D, Imai Y (1994) Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 43: 735-740
28. 28. Cerasi E (1995) Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible? Diabetologia 38: 992-997
29. 29. Ferrannini E (1998) Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 19: 477-490
30. 30. Gerich JE (1998) The genetic basis of Type II diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity. Endocrine Reviews 19: 491-503
31. 31. Kadowaki T, Miyake Y, Hagura R et al. (1984) Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26: 44-49
32. 32. Sicree RA, Zimmet PZ, King HOM, Coventry JS (1987) Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr. Diabetes 36: 179-186
33. 33. Edelstein SL, Knowler WC, Bain RP et al. (1997) Predictors of progression from impaired glucose tolerance to NIDDM. An analysis of six prospective studies. Diabetes 46: 701-710
34. 34. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G (1985) Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 248: E286-E291
35. 35. Lillioja S, Mott DM, Howard BV et al. (1988) Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318: 1217-1225
36. 36. Saad MF, Pettitt DJ, Mott DM, Knowler WC, Nelson RG, Bennett PH (1989) Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet I: 156-1359